Research output per year
Research output per year
- 25 results
Search results
-
2024
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
Crosswell, H. E., LaCasce, A. S., Bartlett, N. L., Straus, D. J., Savage, K. J., Zinzani, P. L., Collins, G. P., Fanale, M., Fenton, K., Dong, C., Miao, H. & Grigg, A. P., Mar 2024, In: Haematologica. 109, 3, p. 982 1 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma
Rutherford, S. C., Yin, J., Pederson, L. D., Blum, K. A., Martin, P., Jung, S. H., Grant, B., Rosenbaum, C., Cheson, B. D., Bartlett, N. L., Mandrekar, S. J. & Leonard, J. P., Mar 26 2024, In: Blood Advances. 8, 6, p. 1464-1468 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis
Epperla, N., Zhao, Q., Moyo, T., Watkins, M. P., Tavakkoli, M., Bello, C., Torka, P., Reddy, N., Thomas, C., Annunzio, K., Christian, B., Barta, S. K., Shouse, G., Olszewski, A. J. & Bartlett, N. L., Feb 13 2024, In: Blood Advances. 8, 3, p. 549-552 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
2023
FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma
Russler-Germain, D. A., Calhoun, B. R., Wu, N., Watkins, M. P., Siegel, B. A., Bartlett, N. L. & Mhlanga, J. C., 2023, In: Leukemia and Lymphoma. 64, 11, p. 1870-1874 5 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Annunzio, K., Grover, N. S., Welkie, R. L., Torka, P., Watkins, M. P., Anampa-Guzmán, A., Tavakkoli, M., Oh, T. S., Reves, H., Jones, D., Hanel, W., Christian, B., Geethakumari, P. R., Karmali, R., Barta, S. K., Bartlett, N. L., Olszewski, A. J. & Epperla, N., 2023, In: Blood Advances. 7, 22, p. 6839-6843 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
Epperla, N., Welkie, R. L., Torka, P., Shouse, G., Karmali, R., Shea, L., Anampa-Guzmán, A., Oh, T. S., Reaves, H., Tavakkoli, M., Lindsey, K., Greenwell, I. B., Hansinger, E., Thomas, C., Chowdhury, S. M., Annunzio, K., Christian, B., Barta, S. K., Geethakumari, P. R. & Bartlett, N. L. & 3 others, , Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 49.Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Epperla, N., Zhao, Q., Chowdhury, S. M., Shea, L., Moyo, T. K., Reddy, N., Sheets, J., Weiner, D. M., Geethakumari, P. R., Kandarpa, M., Bruno, X. J., Thomas, C., Churnetski, M. C., Hsu, A., Zurbriggen, L., Tan, X. W. C., Lindsey, K., Maakaron, J., Caimi, P. F. & Torka, P. & 26 others, , Jan 10 2023, In: Blood Advances. 7, 1, p. 88-91 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
2022
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience
Mehta-Shah, N., Bartlett, N. L., Kahl, B., Watkins, M. P., Dubois, A., Schmelzle, G., Waqar, S., Ballman, C., Wan, F. & Farnsworth, C. W., 2022, In: Leukemia and Lymphoma. 63, 7, p. 1723-1727 5 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Epperla, N., Zhao, Q., Chowdhury, S. M., Shea, L., Moyo, T. K., Reddy, N., Sheets, J., Weiner, D. M., Geethakumari, P. R., Kandarpa, M., Bruno, X. J., Thomas, C., Churnetski, M. C., Hsu, A., Zurbriggen, L., Tan, C., Lindsey, K., Maakaron, J., Caimi, P. F. & Torka, P. & 25 others, , Dec 2022, In: Journal of Hematology and Oncology. 15, 1, 96.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
2021
A forgotten friend: CCNU as palliative monotherapy in relapsed Hodgkin lymphoma
Russler-Germain, D. A., Watkins, M. P. & Bartlett, N. L., 2021, In: Leukemia and Lymphoma. 62, 2, p. 486-488 3 p.Research output: Contribution to journal › Letter › peer-review
-
2020
Diffuse Telangiectatic Rash Associated with Novel Antibody Drug Conjugate Therapies
Sorensen, E. P., Thrush, J., Bartlett, N. L., Rosman, I. S., Anadkat, M. J. & Jones, H. A., May 2020, In: JAMA Dermatology. 156, 5, p. 601-603 3 p.Research output: Contribution to journal › Letter › peer-review
5 Scopus citations -
Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma
Neelapu, S. S., Jacobson, C. A., Oluwole, O. O., Munoz, J., Deol, A., Miklos, D. B., Bartlett, N. L., Braunschweig, I., Jiang, Y., Kim, J. J., Zheng, L., Rossi, J. M. & Locke, F. L., Jun 4 2020, In: Blood. 135, 23, p. 2106-2109 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access103 Scopus citations -
2019
ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study
Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Jan 31 2019, In: Haematologica. 104, 2, p. e65-e67Research output: Contribution to journal › Letter › peer-review
Open Access13 Scopus citations -
Reply to T.M. Weis et al
Bartlett, N. L., Wilson, W. H. & Leonard, J. P., 2019, In: Journal of Clinical Oncology. 37, 31, p. 2953 1 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma
Martin, P., Goy, A., Ramchandren, R., Ferrante, L., Londhe, A., McGowan, T. & Bartlett, N. L., Jun 1 2019, In: Journal of Oncology Pharmacy Practice. 25, 4, p. 1027-1030 4 p.Research output: Contribution to journal › Letter › peer-review
-
2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Rimsza, L. M., Li, H., Braziel, R. M., Spier, C. M., Persky, D. O., Dunlap, J., Leblanc, M., Bartlett, N., Leonard, J. P., Smith, S. M., Press, O. W. & Friedberg, J. W., Mar 23 2018, In: Haematologica. 103, 4, p. e151-e153Research output: Contribution to journal › Letter › peer-review
Open Access35 Scopus citations -
2016
Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria
Rashidi, A., Oak, E., Carson, K. R., Wagner-Johnston, N. D., Kreisel, F. & Bartlett, N. L., May 3 2016, In: Leukemia and Lymphoma. 57, 5, p. 1191-1193 3 p.Research output: Contribution to journal › Letter › peer-review
19 Scopus citations -
2015
Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma
Rashidi, A., Oak, E. & Bartlett, N. L., 2015, In: Blood. 125, 21, p. 3354-3355 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access10 Scopus citations -
2013
Therapy in primary mediastinal B-cell lymphoma [4]
Cashen, A., Christian, B. A. & Bartlett, N., Jul 26 2013, In: New England Journal of Medicine. 369, 3, p. 282-283 2 p.Research output: Contribution to journal › Letter › peer-review
37 Scopus citations -
2012
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma
Foyil, K. V., Kennedy, D. A., Grove, L. E., Bartlett, N. L. & Cashen, A. F., Mar 2012, In: Leukemia and Lymphoma. 53, 3, p. 506-507 2 p.Research output: Contribution to journal › Letter › peer-review
12 Scopus citations -
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin
Wagner-Johnston, N. D., Bartlett, N. L., Cashen, A. & Berger, J. R., Nov 2012, In: Leukemia and Lymphoma. 53, 11, p. 2283-2286 4 p.Research output: Contribution to journal › Letter › peer-review
44 Scopus citations -
2011
Composite diffuse large B-cell lymphoma and precursor B lymphoblastic lymphoma presenting as a double-hit lymphoma with MYC and BCL2 translocation
Nanua, S., Bartlett, N. L., Hassan, A., Robirds, D., Branson, J., Frater, J. L., Nguyen, T. D. T. & Kreisel, F., Nov 2011, In: Journal of Clinical Pathology. 64, 11, p. 1032-1034 3 p.Research output: Contribution to journal › Letter › peer-review
8 Scopus citations -
2008
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study
Lai, R., Bartlett, N. L., Mackey, J. R., Jung, S. H., Johnson, J. L., Cook, J. R., Jones, D., Cass, C. E., Young, J. D., Said, J., Cheson, B. & Hsi, E. D., Jun 2008, In: Leukemia and Lymphoma. 49, 6, p. 1202-1205 4 p.Research output: Contribution to journal › Letter › peer-review
10 Scopus citations -
1999
Bone marrow staging of patients with non-Hodgkin's lymphoma: Is flow cytometry a useful test? [1] (multiple letters)
Auer, I., Luider, J., Naughton, M. J., Hess, J. L., Zutter, M. M. & Bartlett, N. L., Jan 1 1999, In: Cancer. 85, 1, p. 240-241 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access